|
Volumn 95, Issue 19, 2003, Pages 1425-1426
|
Evidence of efficacy: Researchers investigating markers for angiogenesis inhibitors
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANGIOSTATIN;
ANTINEOPLASTIC AGENT;
BASIC FIBROBLAST GROWTH FACTOR;
BEVACIZUMAB;
BIOCHEMICAL MARKER;
CYCLOPHOSPHAMIDE;
CYTOSTATIC AGENT;
CYTOTOXIC AGENT;
ENDOSTATIN;
GROWTH FACTOR;
MATRIX METALLOPROTEINASE;
PLACEBO;
VASCULAR CELL ADHESION MOLECULE 1;
VASCULOTROPIN;
CADHERIN;
COLLAGEN;
ENDOTHELIAL CELL GROWTH FACTOR;
LEUKOCYTE ANTIGEN;
LYMPHOKINE;
MONOCLONAL ANTIBODY;
PEPTIDE FRAGMENT;
PLASMINOGEN;
SIGNAL PEPTIDE;
TUMOR MARKER;
VASCULAR ENDOTHELIAL CADHERIN;
VASCULOTROPIN A;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RESEARCH;
CANCER RESISTANCE;
CANCER SURVIVAL;
CLINICAL STUDY;
CLINICAL TRIAL;
COLORECTAL CANCER;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG TARGETING;
ENDOTHELIUM CELL;
EVIDENCE BASED MEDICINE;
HUMAN;
MAXIMUM PERMISSIBLE DOSE;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROGNOSIS;
RELIABILITY;
STEM CELL;
TUMOR BIOPSY;
TUMOR REGRESSION;
ANIMAL;
ARTICLE;
CYTOLOGY;
GENETICS;
NEOPLASM;
RESEARCH;
VASCULAR ENDOTHELIUM;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANGIOSTATINS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD;
ANTINEOPLASTIC AGENTS;
CADHERINS;
COLLAGEN;
ENDOSTATINS;
ENDOTHELIAL GROWTH FACTORS;
ENDOTHELIUM, VASCULAR;
EVIDENCE-BASED MEDICINE;
HUMANS;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
LYMPHOKINES;
NEOPLASMS;
PEPTIDE FRAGMENTS;
PLASMINOGEN;
RESEARCH;
STEM CELLS;
TUMOR MARKERS, BIOLOGICAL;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 0142106337
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (17)
|
References (0)
|